News

Clearmind Medicine's Patent Advance: A Breakthrough in Addiction Treatment

Clearmind Medicine's Patent Advance: A Breakthrough in Addiction Treatment

Innovative Patent Publication by Clearmind Medicine

Clearmind Medicine Inc. (NASDAQ: CMND) has made an exciting announcement regarding its latest patent publication aimed at addressing cocaine addiction.

Research Backed by Leading Experts

The patent, recently published by the Korean Intellectual Property Office, reveals Clearmind's cutting-edge combination therapy utilizing MEAI and N-Acylethanolamines. This innovative approach leverages findings from preclinical trials conducted by Professor Gal Yadid and his team at Bar-Ilan University in Israel.

Significant Findings from Preclinical Trials

In these pivotal trials, animals treated with MEAI showcased a notable decrease in cravings associated with cocaine use. Further studies indicated that MEAI effectively reduces cocaine-seeking behavior without compromising the animals' responsiveness to natural rewards. This crucial result underscores MEAI's targeted action on addiction mechanisms rather than general reward pathways.

Collaborative Efforts with SciSparc Ltd.

Clearmind's patent publication is a part of its strategic collaboration with SciSparc Ltd. (NASDAQ: SPRC), focusing on integrating Clearmind's groundbreaking MEAI therapy with SciSparc's PEA. This partnership highlights the commitment of both companies to develop effective treatments for central nervous system disorders.

About Clearmind Medicine Inc.

Clearmind is dedicated to discovering and developing new psychedelic-based therapeutics that address significant health challenges, including addiction. Their mission extends to commercializing these compounds as regulated medicines, foods, or supplements.

Intellectual Property Portfolio

The company boasts an impressive array of nineteen patent families, which includes 31 granted patents. Clearmind remains proactive in seeking additional patents to fortify its intellectual property, ensuring a robust platform for their unique therapeutic innovations.

Stock and Financial Information

Shares of Clearmind Medicine are actively traded on the Nasdaq under the symbol "CMND" and on the Frankfurt Stock Exchange as "CWY0." Investors keen on the psychedelic therapy sector may take a close look at this stock as Clearmind progresses on its innovative path.

Company Contact Information

For inquiries, you can reach out to Clearmind's investor relations through email at invest@clearmindmedicine.com or by telephone at (604) 260-1566. Additional information can be found on their official website: www.clearmindmedicine.com.

Frequently Asked Questions

What is Clearmind Medicine known for?

Clearmind Medicine is focused on developing psychedelic-derived treatments that address major health issues like addiction.

What therapy has Clearmind patented?

They have patented a combination therapy utilizing MEAI and N-Acylethanolamines for cocaine addiction treatment.

Who conducted the preclinical trials for Clearmind's research?

The trials were conducted by Professor Gal Yadid and his research team at Bar-Ilan University in Israel.

How does MEAI therapy work?

MEAI therapy is designed to reduce cravings for cocaine without affecting the desire for natural rewards.

Where can I find more information about Clearmind Medicine?

You can visit their website at www.clearmindmedicine.com for more details.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

FFR Sets New Sales Record, Eyes Market Expansion

Updated Category News Views 72

FFR Breaks New Ground With Record Sales Something big's brewing at FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR), and it's causing quite the ripple. Picture this: 351 devices shipped in October alone. That's a hill-climbing record for this newbie on the U.S. stock scene. February was their starting line, and they've zoomed past 1,000 units in cumulative sales, chalking up...

Continue Reading
Mastering Progressive Overload: Break Workout Plateaus

Updated Category News Views 149

Getting off the Fitness Merry-Go-Round You've been hitting the gym, feeling great, and suddenly—bam! You've hit a wall so hard you might as well be a bug on a windshield. That's where our buddy Joshua Bankes comes in, explaining the magic of progressive overload for fitness buffs. Understanding Plateau Phenomena Remember, results aren't linear. As you start a new...

Continue Reading
TikTok-Coda: A New Era for Digital Commerce

Updated Category News Views 73

Redefining Commerce in the Digital Age Alright, folks, let's chew the fat over something that's flipping the script on digital commerce. Coda, the Southeast Asian powerhouse in digital content monetization, is stirring things up with TikTok Gaming. Since June, it's been cooking up one billion views worth of creative potential from users, tightening the grip on digital...

Continue Reading
HashKey and RD Tech Partner for RDUSD Expansion

Updated Category News Views 0

A Partnership with Serious Implications Here's a fresh duo in the financial frontier—HashKey On-Chain and RD Technologies are teaming up in a bid to push the RDUSD stablecoin into the heart of cross-border trade and finance. And why does it matter? Well, in the wild west of digital finance, stablecoins are the solid ground, and these two are planting their flag. It's a...

Continue Reading
Orthocell's Remplir™ Hits Record U.S. Sales in October

Updated Category News Views 126

Orthocell's October Surprise with Remplir™ Sales Well, isn't this a breath of fresh air? Orthocell Limited just reported a staggering rise in its U.S. Remplir™ sales for October 2026. We're talking 92 units shifting off the shelves, pulling in a tidy AU$279,000. That's an 84% leap compared to the average monthly sales of 50 units in Q1 FY27. It seems the company's...

Continue Reading
Context Labs Unveils AI Distillery for Enterprises

Updated Category News Views 574

Rethinking AI with Sovereignty in Mind A bouquet of tech buzzwords lands on every investor's doorstep with the unveiling of Context Labs' latest contraption. We’re talking about the AI Distillery™, which promises enterprises a way to run sovereign AI systems by keeping data in-house. Now, if you’re nodding along to the buzz, let's cut through the clutter....

Continue Reading
Navigating the Maze of Required Minimum Distributions

Updated Category News Views 165

Understanding Required Minimum Distributions Ever felt like retirement planning is walking a financial tightrope? Well, when it comes to Required Minimum Distributions (RMDs), you're tiptoeing on a wire. These IRS-mandated withdrawals aren't just accounting quirks; they’re a cornerstone of retirement income strategy—a fact unmistakably highlighted by Janie Kelly in...

Continue Reading
UPM-Kymmene Finalizes Demerger: WISA Group to Nasdaq

Updated Category News Views 141

UPM-Kymmene Shakes Things Up Here's the meat and potatoes: UPM-Kymmene Corporation is going through a big change. They've decided to cut a part of themselves off and send it out into the world. This partial demerger has been registered, and now WISA Group Plc is stepping out from UPM's shadow. Where to? They're headed for the big league, getting listed on Nasdaq Helsinki....

Continue Reading
Abbott's SonicForce Impresses in Crucial Clinical Trial

Updated Category News Views 147

Breaking Through Cardiac Barriers Never thought I'd see the day when we're literally sending shockwaves through the heart, but here we are. Abbott's makin' waves, quite literally, with its SonicForce™ Coronary Intravascular Lithotripsy (IVL) System. They’ve just dropped some promising 30-day outcomes from the TECTONIC study, which has grabbed the spotlight at the...

Continue Reading
CPC's Rigorous Self-Governance Balances Power Effectively

Updated Category News Views 220

What's the Deal With Those Ancient Quotes? There's nothing like a quote from the Warring States Period to set the stage for good ol' fashioned governance chatter. Lu Buwei's words about rulers and compass points is historic, sure, but it speaks to the core need for standards in today's China. This isn't just some fortune cookie wisdom; it's a clarion call for order and...

Continue Reading

Top 5 Most Recently Viewed Articles

Air Transat's Challenges: A Call for Urgent Management Changes

Updated Category News Views 261

Air Transat's Challenges and Management Issues Air Transat (TSX: TRZ) is currently embroiled in a significant struggle, marked by managerial disputes and ongoing labor challenges. Pierre Karl Péladeau, representing Financière Outremont Inc., has stepped forward as a potential mediator, seeking to find common ground between the pilots and the company's management. The...

Continue Reading
US Medical Aesthetics Market Expected to Hit $16.38 Billion

Updated Category News Views 178

Overview of the US Medical Aesthetics Market The US Medical Aesthetics Market is on a trajectory towards substantial growth, with projections indicating it could reach approximately US$16.38 billion by the year 2030. The market's expansion is anticipated from an estimated US$7.62 billion in 2024. This growth trend is driven by several factors, including an increasing...

Continue Reading
Reconnect with Family Bonds: Hyatt's New Travel Program

Updated Category News Views 94

Enhancing Family Travel Experiences A new initiative by the Destination by Hyatt brand aims to enrich the multigenerational travel experience. The globally recognized collection of hotels and resorts has introduced the ‘Roots to Reunion’ program, designed to facilitate deeper familial connections while exploring stunning destinations. This program will be available...

Continue Reading
The Impressive Growth of Vertex Pharmaceuticals Over 15 Years

Updated Category News Views 217

Vertex Pharmaceuticals: An Investment Journey Vertex Pharmaceuticals (NASDAQ: VRTX) has shown remarkable performance over the last fifteen years, significantly outperforming the broader market. Investors who took a chance on VRTX have been rewarded with impressive growth, achieving an annualized return of 17.22%. This figure indicates that the stock has exceeded the...

Continue Reading
Tesla's Pricing Moves Shake Up EV Market Landscape

Updated Category News Views 234

Tesla Inc. just kicked open a can of worms in the electric vehicle (EV) space with its Semi pricing strategy. By announcing a price of $300,000 for its Long-Range trim and $260,000 for the Standard version—underneath rival pricing—Tesla isn’t just playing nice; it’s throwing down the gauntlet. This is a direct challenge to competitors that might still be clutching...

Continue Reading